Cargando…

Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant

Detalles Bibliográficos
Autores principales:	Shipton, Michael J., Kinsella, Paul M., Davis, Thomas, Azzato, Francesca, Taiaroa, George, Szer, Jeff, Routledge, David, Smibert, Olivia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995889/ https://www.ncbi.nlm.nih.gov/pubmed/35411105 http://dx.doi.org/10.1038/s41409-022-01669-8

Ejemplares similares

Acute hyperammonaemic encephalopathy
por: Ng, Peng Soon, et al.
Publicado: (2014)

Non-hyperammonaemic valproate encephalopathy after 20 years of treatment
por: Caruana Galizia, Elizabeth, et al.
Publicado: (2017)

Hyperammonaemic Encephalopathy Caused by Adult-Onset Ornithine Transcarbamylase Deficiency
por: Niclasen, Bjarke Hammer, et al.
Publicado: (2022)

Hyperammonaemic encephalopathy: a remarkably rare complication after bariatric surgery
por: Jhamb, Shaurya, et al.
Publicado: (2023)

A Case of Fatal Hyperammonaemic Encephalopathy in a Patient with End-Stage Multiple Myeloma
por: Passucci, Mauro, et al.
Publicado: (2023)

Acquired urea cycle amino acid deficiency and hyperammonaemic encephalopathy in a cat with inflammatory bowel disease and chronic kidney disease
por: Dor, Cécile, et al.
Publicado: (2018)

COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome
por: Lupo-Stanghellini, Maria Teresa, et al.
Publicado: (2021)

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
por: Sora, Federica, et al.
Publicado: (2022)

Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection
por: Christopeit, Maximilian, et al.
Publicado: (2021)

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
por: Szer, Jeff, et al.
Publicado: (2020)

Significance of men’s health in long-term survivors of allogeneic stem cell transplantation
por: Schneidewind, Laila, et al.
Publicado: (2022)

Wernicke's encephalopathy following allogeneic hematopoietic stem cell transplantation
por: Choi, Yoon Ji, et al.
Publicado: (2010)

Cerebral toxoplasmosis after allogeneic hematopoietic stem cell transplantation diagnosed by megagenomic analysis
por: Shen, Kai, et al.
Publicado: (2019)

Immunoglobulin and granulocyte-colony stimulating factor affecting infection and hematopoietic reconstruction in allogeneic hematopoietic stem cell transplantation
por: Ma, Le, et al.
Publicado: (2023)

Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning
por: Morsink, L. M., et al.
Publicado: (2022)

Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
por: Zhao, Chenchen, et al.
Publicado: (2022)

Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia
por: Zhang, Bing-Lei, et al.
Publicado: (2019)

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
por: Pophali, Prateek, et al.
Publicado: (2020)

A case of lupus miliaris disseminatus faciei after allogeneic hematopoietic stem cell transplantation
por: Zhang, Si, et al.
Publicado: (2019)

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
por: Sellner, Leopold, et al.
Publicado: (2020)

Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19
por: Niederwieser, Christian, et al.
Publicado: (2022)

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021)

First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up
por: Kuskonmaz, Baris, et al.
Publicado: (2022)

CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation
por: Calderin Sollet, Zuleika, et al.
Publicado: (2023)

COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
por: Niu, Alex, et al.
Publicado: (2020)

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
por: Duraković, Nadira, et al.
Publicado: (2021)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
por: Pabon, Cindy M., et al.
Publicado: (2021)

Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia
por: Hassan, Mona Ali, et al.
Publicado: (2023)

Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience
por: Mediwake, Heshani, et al.
Publicado: (2017)

Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma
por: Yang, Luxin, et al.
Publicado: (2018)

High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant
por: Baranwal, Anmol, et al.
Publicado: (2022)

The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation
por: Yoshida, Shota, et al.
Publicado: (2022)

2743. Pre-Transplant Human T-Lymphotropic Virus Screening In Allogeneic Hematopoietic Stem Cell Transplant Recipients At A Large Metropolitan Tertiary Referral Centre In Melbourne, Australia
por: Paykin, Gabriel, et al.
Publicado: (2023)

Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
por: Vinci, Luca, et al.
Publicado: (2023)

Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
por: Wang, Xiaodong, et al.
Publicado: (2021)

Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma
por: Yang, Fan, et al.
Publicado: (2022)

Paraplegia as Manifestation of an Isolated Central Nervous System Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation in a Woman with Acute Myelogenous Leukemia
por: Yang, Bi-Hui, et al.
Publicado: (2016)

Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2021)

Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19
por: Roedl, Kevin, et al.
Publicado: (2021)

Co-occurrence of Multiple Sclerosis and Severe Aplastic Anemia: A Report of Two Cases Successfully Treated with Allogeneic Hematopoietic Stem Cell Transplantation
por: Haroon, Alfadil, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hmgt17p4133d72ncunc5hde7gs